Prealize operates a predictive healthcare analytics company. It offers a predictive analytics platform that anticipates when costly care events will occur, helping healthcare providers shift from reactive to proactive healthcare. The company primarily sells to health plans, employers, and providers across the nation. Prealize was formerly known as Cardinal Analytx. It was founded in 2015 and is based in San Francisco, California.
ESPs containing Prealize
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The health risk scoring market includes tech providers with solutions to evaluate the likelihood of an individual developing certain health conditions or experiencing adverse health events. Many of these solutions are powered by artificial intelligence. Healthcare payers, providers, and individuals can use these scores to inform decisions about care options, risk monitoring, prevention, and insura…
Research containing Prealize
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Prealize in 3 CB Insights research briefs, most recently on Nov 10, 2023.
Expert Collections containing Prealize
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Prealize is included in 3 Expert Collections, including Artificial Intelligence.
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Value-Based Care & Population Health
Latest Prealize News
Mar 28, 2023
March 28, 2023 Proven healthcare executive brings with her an extensive leadership, sales and marketing background within the technology, health plan and service industries Prealize, an artificial intelligence (AI)-enabled predictive analytics company, today announced the appointment of healthcare executive Kyle Raffaniello to their Board of Directors. Ms. Raffaniello is a proven leader in the healthcare industry, having led technology and service companies for the past 20 years. Currently, she serves as the President of Sapphire, a division of Zelis. Previously, she was the CEO of Sapphire Digital. “The healthcare industry is increasingly embracing predictive analytics and AI to help forecast risk and costs, and suggest proactive care options. Prealize is extending its leadership by adding Kyle Raffaniello to our Board,” said John Doerr , chairman of venture capital firm Kleiner Perkins. “Kyle is a well-respected and seasoned healthcare executive who brings with her a passion for healthcare technology and a strong background in growing lines of business.” During her career, Ms. Raffaniello was also the Chief Strategy Officer and Executive Vice President of ValueOptions, a behavioral health company that was sold to Beacon Health in 2014. Prior to that, she was Senior Vice President of Sales and Marketing for Consortium Health Plans, an organization that was focused on account growth and retention for the nation’s 20 largest Blue Cross Blue Shield plans. She has also held several senior sales and marketing positions at a variety of regional health plans, as well as led provider relations for several large medical delivery systems. A graduate of Mount St. Mary’s College, she also earned her graduate degree in Healthcare Administration from George Washington University. “I am both honored and excited to be appointed to the Prealize Health board. This is a time of tremendous potential and opportunity for the company, as machine learning and predictive analytics continue to develop into game-changing technology that will impact the quality and cost of care. I look forward to helping drive the vision and strategy for the company going forward,” said Raffaniello. previous post
Prealize Frequently Asked Questions (FAQ)
When was Prealize founded?
Prealize was founded in 2015.
Where is Prealize's headquarters?
Prealize's headquarters is located at 85 Burnett Avenue, San Francisco.
What is Prealize's latest funding round?
Prealize's latest funding round is Series C - II.
How much did Prealize raise?
Prealize raised a total of $47.22M.
Who are the investors of Prealize?
Investors of Prealize include Cardinal Partners, Kleiner Perkins Caufield & Byers, John Doerr, Premera Blue Cross, Blue Shield of California and 5 more.
Who are Prealize's competitors?
Competitors of Prealize include KenSci and 5 more.
Compare Prealize to Competitors
ClosedLoop operates as a healthcare data science platform. It enables providers, payers, and value-based care organizations to make accurate, explainable, and actionable predictions of individual-level health risks, improve outcomes, and reduce costs. It was formerly known as Deep Health Technologies. The company was founded in 2017 and is based in Austin, Texas.
Decode Health is a precision medicine analytics company that fuels collaboration within pharmaceutical, diagnostic, and technology companies. The company leverages its platform and expertise in genomics, clinical data, social determinants of health, and other healthcare data sources, to bring actionable insights into focus quickly. It creates data assets, products, and services that improve patient outcomes and reduce costs. Projects include genomic data creation, biomarker discovery, RNA diagnostics, and broader population health analytics. Decode Health was founded in 2019 and is headquartered in Nashville, Tennessee.
Medial EarlySign is a company that focuses on the development of machine learning-based decision support tools in the healthcare industry. The company's main services include the creation of predictive models that can identify individuals who are more likely to have a serious condition based on the analysis of existing clinical data. These models provide actionable insights and enable healthcare organizations to offer proactive, personalized, and predictive care management. The company primarily sells to organizations across the healthcare continuum, including diagnostic and pharmaceutical companies, medical centers, and researchers. It was founded in 2013 and is based in Hod Hasharon, Israel.
Epic specializes in the development of software for healthcare organizations.
Color operates as a healthcare technology company democratizing access to genetic information. It offers color tests for patients to detect hereditary cancers such as breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach, and uterine cancers. Color was formerly known as Color Global. It was founded in 2014 and is based in Burlingame, California.
AKASA operates as artificial intelligence (AI) powered automation company. It uses machine learning to provide health systems with a single solution for automating revenue cycle operations. It was founded in 2018 and is based in South San Francisco, California.